Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Bissonnette

Showing results (71-80 of 222) with videos related to

Pageof 23
Sort By:
Journal of the American Academy of Dermatology|September 18, 2017
Use of capsule endoscopy to identify lesions suggestive of Crohn's disease in patients with moderate to severe psoriasisRobert Bissonnette, Raja Tamaz, Chantal Bolduc, et al.
Cutis|February 27, 2010
Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasisYves Poulin, Kim Papp, Robert Bissonnette, et al.
Journal of Drugs in Dermatology : JDD|July 8, 2017
Prospective Study of Pathogenesis of Atrophic Acne Scars and Role of Macular ErythemaJerry Tan, Valérie Bourdès, Robert Bissonnette, et al.
Photodermatology, Photoimmunology & Photomedicine|September 20, 2018
Ultraviolet B-induced immunosuppression is not associated with receptor activator of nuclear factor kappa B ligand upregulation in human skinEtienne Saint-Cyr Proulx, Shunya Mashiko, Catherine Maari, et al.
American Journal of Clinical Dermatology|June 19, 2019
Long-Term Effectiveness and Safety of Up to 48 Weeks' Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial AcneBrigitte Dréno, Robert Bissonnette, Angélique Gagné-Henley, et al.
The Journal of Allergy and Clinical Immunology|January 31, 2021
Biomarkers in atopic dermatitis-a review on behalf of the International Eczema CouncilYael Renert-Yuval, Jacob P Thyssen, Robert Bissonnette, et al.
Journal of the American Academy of Dermatology|March 30, 2016
Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasisRobert Bissonnette, David M Pariser, Norman R Wasel, et al.
Journal of the American Academy of Dermatology|February 18, 2010
A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasisRobert Bissonnette, Kim Papp, Catherine Maari, et al.
Allergy|May 10, 2023
Oral prednisone regulates human skin T cells in delayed-type hypersensitivity reaction elicited by diphencyproneHeena Mehta, Carolyn Jack, Catherine Maari, et al.
Plos One|June 22, 2016
Correction: Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis VulgarisRobert Bissonnette, Mayte Suárez-Fariñas, Xuan Li, et al.
Pageof 23

Showing results (71-80 of 222) with videos related to

Sort By:
Pageof 23
Journal of the American Academy of Dermatology|September 18, 2017
Use of capsule endoscopy to identify lesions suggestive of Crohn's disease in patients with moderate to severe psoriasisRobert Bissonnette, Raja Tamaz, Chantal Bolduc, et al.
Cutis|February 27, 2010
Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasisYves Poulin, Kim Papp, Robert Bissonnette, et al.
Journal of Drugs in Dermatology : JDD|July 8, 2017
Prospective Study of Pathogenesis of Atrophic Acne Scars and Role of Macular ErythemaJerry Tan, Valérie Bourdès, Robert Bissonnette, et al.
Photodermatology, Photoimmunology & Photomedicine|September 20, 2018
Ultraviolet B-induced immunosuppression is not associated with receptor activator of nuclear factor kappa B ligand upregulation in human skinEtienne Saint-Cyr Proulx, Shunya Mashiko, Catherine Maari, et al.
American Journal of Clinical Dermatology|June 19, 2019
Long-Term Effectiveness and Safety of Up to 48 Weeks' Treatment with Topical Adapalene 0.3%/Benzoyl Peroxide 2.5% Gel in the Prevention and Reduction of Atrophic Acne Scars in Moderate and Severe Facial AcneBrigitte Dréno, Robert Bissonnette, Angélique Gagné-Henley, et al.
The Journal of Allergy and Clinical Immunology|January 31, 2021
Biomarkers in atopic dermatitis-a review on behalf of the International Eczema CouncilYael Renert-Yuval, Jacob P Thyssen, Robert Bissonnette, et al.
Journal of the American Academy of Dermatology|March 30, 2016
Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasisRobert Bissonnette, David M Pariser, Norman R Wasel, et al.
Journal of the American Academy of Dermatology|February 18, 2010
A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasisRobert Bissonnette, Kim Papp, Catherine Maari, et al.
Allergy|May 10, 2023
Oral prednisone regulates human skin T cells in delayed-type hypersensitivity reaction elicited by diphencyproneHeena Mehta, Carolyn Jack, Catherine Maari, et al.
Plos One|June 22, 2016
Correction: Based on Molecular Profiling of Gene Expression, Palmoplantar Pustulosis and Palmoplantar Pustular Psoriasis Are Highly Related Diseases that Appear to Be Distinct from Psoriasis VulgarisRobert Bissonnette, Mayte Suárez-Fariñas, Xuan Li, et al.
Pageof 23